Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-11
2010-10-12
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S350000, C549S424000
Reexamination Certificate
active
07812027
ABSTRACT:
The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
REFERENCES:
patent: 6087392 (2000-07-01), Reiter
patent: 2005/0065144 (2005-03-01), Feng et al.
patent: 2007/0232676 (2007-10-01), Biftu et al.
patent: 2007/0254865 (2007-11-01), Biftu et al.
patent: 2008/0009510 (2008-01-01), Edmondson et al.
patent: 2008/0076773 (2008-03-01), Cox et al.
patent: WO 2006/009886 (2006-01-01), None
patent: WO 2006/039325 (2006-04-01), None
patent: WO 2006/039325 (2006-04-01), None
patent: WO 2006/058064 (2006-06-01), None
patent: WO 2006/058064 (2006-06-01), None
patent: WO 2006/127530 (2006-11-01), None
patent: WO 2007/024993 (2007-03-01), None
patent: WO 2007/024993 (2007-03-01), None
patent: WO 2007/070434 (2007-06-01), None
patent: WO 2007/070434 (2007-06-01), None
patent: WO 2007/087231 (2007-08-01), None
patent: WO 2007/087231 (2007-08-01), None
patent: WO 2007/097931 (2007-08-01), None
patent: WO 2007/097931 (2007-08-01), None
patent: WO 2007/126745 (2007-11-01), None
patent: WO 2007/126745 (2007-11-01), None
patent: WO 2007/136603 (2007-11-01), None
patent: WO 2007/136603 (2007-11-01), None
Moses, R. et al., “Effect of Repaglinide Addition to Metformin Monotherapy on Glycemic Control in Patients with Type 2 Diabetes” Diabetes Care, vol. 11, No. 1, pp. 119-124, 1999.
Biftu Tesfaye
Chen Ping
Feng Danqing
Weber Ann E.
Fair Janet E.
Merck Sharp & Dohme Corp.
Todaro John C.
Willis Douglas M
Wilson James O
LandOfFree
Substitued [1,2,4]triazolo[1,5-a]pyrazines as dipeptidyl... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substitued [1,2,4]triazolo[1,5-a]pyrazines as dipeptidyl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substitued [1,2,4]triazolo[1,5-a]pyrazines as dipeptidyl... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4218972